New cancer diagnostic tool could change how doctors choose treatments
NCT ID NCT07403630
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new platform that uses advanced testing to get a complete picture of a person's tumor. The goal is to see if this detailed information can help doctors choose better treatments for patients with high-risk cancers like leukemia, multiple myeloma, and pancreatic cancer. About 300 patients aged one year and older will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AO Riuniti Villa Sofia-Cervello di Palermo
RECRUITINGPalermo, Palermo, 90146, Italy
-
University of Perugia
RECRUITINGPerugia, Perugia, 06123, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a Bag-Like device pull bladder tumors out whole?
- Can new drug cocktails reawaken the immune system against melanoma?
- Could a vaccine help fight Hard-to-Treat cancers?